The US Justice Department has moved to reclassify certain medical marijuana products as less dangerous drugs than their previous Schedule I status, which designated cannabis as a drug with no medical use and high potential for abuse. The decision was made by President Donald Trump, who stated that it seemed like the best solution for major problems. The move does not legalize marijuana on a federal level but reduces restrictions on federally funded medical research and reduces it on the list of federal law enforcement priorities. The DEA will hold a hearing in June to consider reclassifying recreational cannabis from Schedule I to Schedule II. The reclassification follows an executive order signed by Trump in December 2025 from the Justice Department to re-evaluate medical marijuana and open the way for CBD products.